convalescent COVID 19 Plasma
/ Hematology and Internal Medicine Center
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 22, 2020
COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma
(clinicaltrials.gov)
- P2; N=10; Recruiting; Sponsor: Centro de Hematología y Medicina Interna
New P2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1